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Synthesis of Azasteroids
Synthesis of Steroidal D-Ring-Fused Pyrrolidines of
Dehydroepiandrosterone
Daniel Blanco-Ania,*[a] René W. M. Aben,[a] Leon W. A. van Berkom,[a] Hans W. Scheeren,[a]
and Floris P. J. T. Rutjes[a]
Abstract: The commercially available steroid dehydroepiandro-
sterone 3-acetate (DHEA) was converted into steroidal D-ring-
fused pyrrolidines that combine two privileged structures: a
steroid and a (2-arylethyl)amine. The three-step transformations
proceeded through conversion of the C-17 ketone into an enol
Introduction
Steroids fused through the D-ring to various types of hetero-
cycles, including pyridines,[1] pyrimidines,[2] pyridazines,[3]
thiazoles,[4] imidazoles,[1b] pyrazoles,[5] indoles,[6] and polyhet-
erocyles,[4,7] have become part of a growing research field.
Members of this class of compounds, which are based on the
combination of two medicinally relevant privileged core struc-
tures into a single molecule, show diverse biological activities.
Interestingly, in several cases, these activities are higher than
those of the corresponding steroidal reference drugs.[8] The
high therapeutic potential of these steroidal alkaloids against
cancer and other diseases has recently been reviewed.[9]
The compounds solanidine (1a) and solanine (1b; Fig-
ure 1),[10] which contain a pyrrolidine ring fused to the steroid
skeleton, are primary examples of this class of compounds.
Solanine in particular has attracted much attention because of
its antitumor activity.[11]
As part of our research into the preparation of new hetero-
cycle-fused steroids with possible biological activity, in this pa-
per we present new compounds in which the following two
privileged structures are combined: (1) (acetyl-protected) dehy-
droepiandrosterone (DHEA; 2), an endogeneous steroid hor-
mone; and (2) a (2-arylethyl)amine moiety (3) contained within
a pyrrolidine framework, another common feature in biologi-
cally active natural products and pharmaceutical agents
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ether, followed by high-pressure-mediated cascade [4+2]/[3+2]
cycloadditions with two nitroalkenes ([4+2]) and five dipolaro-
philes ([3+2]) to yield azonite intermediates. Finally, reduction
of these azonites formed the new azasteroids, which are suit-
able for further derivatization.
Figure 1. Biologically active pyrrolidine-fused steroids.
(Scheme 1).[12] It is important to emphasize the biological rele-
vance of the (2-arylethyl)amine moiety, which is encountered in
numerous compounds that act on the central nervous system.
Scheme 1. Combination of (acetyl-protected) DHEA (2) and (2-arylethyl)amine
(3) in a pyrrolidine ring.
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Furthermore, this privileged structure is present in neurotrans-
mitters such as dopamine, epinephrine, norepinephrine, and
serotonin.[13] We also present model compounds that lack the
steroid framework, but helped with the elucidation of the
stereochemical outcome of the reactions, and that could shed
light on the mechanism of action in a drug-discovery program.
A sequence suitable for this synthesis was recognized in the
cascade [4+2]/[3+2] cycloadditions studied by Denmark and
others.[14] In this approach, a nitroalkene (e.g., nitrostyrene) re-
acts with an enol ether to form a six-membered cyclic azinate
(formerly known as nitronate), which then reacts further with a
selected alkene in a 1,3-dipolar cycloaddition reaction to pro-
duce an azonite. From there, (arylethyl)amines are accessible by
reduction of the azonite functionality. A retrosynthesis of the
target compounds is presented in Scheme 2. Starting from the
anticipated pyrrolidine derivatives 17–24, the pyrrolidine rings
could be derived from compounds 6–16 by reduction of the
azonites and subsequent intramolecular reductive amination. A
multicomponent cycloaddition should take place to generate
these compounds from enol ethers 4 and 5, which in turn could
be derived from cyclopentanone and acetyl-protected DHEA (2;
Scheme 2). It was discovered by Uitenbogaard et al. that the
[4+2]/[3+2] cycloaddition is greatly accelerated by the use of
high pressure.[15] High pressure is also important to overcome
the low reactivity of the C-17 position of steroids due to the
presence of the C-ring and the methyl group (C-18) at the C–
D ring junction.[16] Thus, we were prompted by the synthetic
challenge to synthesize a pyrrolidine E-ring fused to DHEA
through a high-pressure-promoted cycloaddition reaction.
Scheme 2. Retrosynthetic analysis for the synthesis of pyrrolidine derivatives
17–24.
Results and Discussion
The synthesis of the model compounds began with the known
formation of enol ether 4.[17] The high-pressure-promoted mul-
ticomponent cycloadditions were carried out with enol ether
4, nitroalkene 25, and dipolarophiles with different functional
groups (26–30).[18,19] The [4+2] and [3+2] cycloaddition reac-
tions took place with complete regioselectivity[20] to give azon-
ites 6–10 as mixtures of only two diastereoisomers (a and b),
via azinate intermediates 31 (Scheme 3, Table 1). In most cases,
only the major isomer (a) could be isolated in pure form. The
cycloaddition reactions of the electron-deficient dipolarophiles
(Table 1, Entries 2 and 4) gave higher product yields than the
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reactions of electron-rich alkenes (Table 1, Entries 1, 3, and 5).
These results were expected, based on the known HOMOazinate–
LUMOdipolarophile interaction.[21] No product from the competing
cycloaddition of azinate 31 with enol ether 4 was observed,
probably because of the higher steric hindrance of this tri-
substituted alkene compared with the monosubstituted di-
polarophiles, and the higher energy of its LUMO.
Scheme 3. Multicomponent reactions of enol ether 4 to form azonites 6–10.
Table 1. Synthesis of azonites 6–10.
Entry Dipolarophile (R1) Products (ratio)[a][22] Yield [%][b]
1 26 (Ph) 6a/6b (17:1) 64
2 27 (CO2Me) 7a/7b (3:1) 82
3 28 [CH(OCH2)2] 8a/8b (9:1) 59
4 29 (CN) 9a/9b (4:3) 75
5 30 (OAc) 10a/10b (6:1) 67
[a] Calculated from the isolated products after purification. It was not possible
to determine the ratio from the crude mixtures. [b] Combined yield.
Stereochemical elucidation was carried out based on the sin-
gle-crystal X-ray diffraction analysis of compound 7a and exten-
sive NMR spectroscopic analysis of 7a and 7b (Figure 2).[23]
These two compounds show the same coupling pattern and
the same coupling constant values for 3a-H (q, J = 8.1–8.2 Hz),
indicating a similar dihedral angle and therefore the same con-
figuration at C-3a.
Figure 2. (a) X-ray crystal structure of compound 7a; and (b) NMR spectro-
scopic analysis of 7a and 7b.
The stereoisomerism of azinate 31 could be explained by a
stereoselective hetero-Diels–Alder cycloaddition of nitroalkene
25 and the heterodiene with the methoxy group approaching
in an endo fashion (Scheme 4).[24]
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Scheme 4. Hetero-Diels–Alder cycloaddition for the formation of azinate 31.
Then, a regio- and stereoselective 1,3-dipolar cycloaddition
of azinates 31 and dipolarophiles 26–30 yielded azonites 6–10.
In all cases, the major products were formed through an exo
approach of the dipolarophile exclusively on the Re face of the
azinates, probably because of the presence of the phenyl group
(Scheme 5).
Scheme 5. Stereoselective formation of azonites 6–10.
The final pyrrolidines were synthesized by reduction of the
corresponding azonites. Azonites 6a–10a were hydrogenated
with Raney nickel in methanol at room temperature to give
pyrrolidines 17a–20a in fair to excellent yields (Scheme 6,
Table 2).[25] Azonite 7a formed a mixture of pyrrolidine 18a and
pyrrolizidinone 34a (Table 2, Entry 2)[26] by cyclization of the
pyrrolidine with the ester.[27] Pyrrolidines 17a–20a were formed
by the stereoselective reduction of imines 33,[28] which in turn
were presumably formed by intramolecular condensation of
Scheme 6. Reduction of azonites 6a–10a to form pyrrolidines 17a–20a and
pyrrolizidinone 34a.
Table 3. Synthesis of azonites 11–16.
Entry Heterodiene (R2) Dipolarophile (R1) Products (ratio)[a][22] Yield [%][b]
1 25 (Ph) Ph 11a/11b (5:1) 66
2 25 (Ph) CO2Me 12a/12b/12c (13:4:6) 68
3 25 (Ph) CH(OCH2)2 13a/13b (7:2) 41
4 25 (Ph) CN 14a/14b/14c (11:9:6) 79
5 25 (Ph) OAc 15a/15c (5:1) 54
6 35 (PhCH=CH) CO2Me 16a/16b/16c (8:2:9) 71
[a] Calculated from the isolated products after purification. It was not possible to determine the ratio from the crude mixtures. [b] Combined yield.
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amino hydroxy ketones 32, plausible intermediates after the
reduction of azonites 6a–10a. The reduction of azonite 10a did
not provide the corresponding pyrrolidine, but gave mixtures
of unidentified compounds.
Table 2. Synthesis of pyrrolidines 17a–20a and pyrrolizidinone 34a.
Entry Azonite R1 Product(s) R3 Yield [%]
1 6a Ph 17a Ph 74
2 7a CO2Me 18a + 34a CO2Me 41 + 53
3 8a CH(OCH2)2 19a CH(OCH2)2 66
4 9a CN 20a CH2NH2 56[a]
5 10a OAc – – –
[a] The product was isolated as the triacetyl derivative.
The synthesis of the corresponding steroid derivatives took
place similarly to the synthesis of the model compounds. Treat-
ment of acetyl-protected DHEA (2) with trimethyl orthoformate
in methanol with H2SO4 as catalyst gave the corresponding di-
methyl acetal, and subsequent demethanolization by distilla-
tion gave enol ether 5 in 63 % yield.[29] The high-pressure-pro-
moted multicomponent cycloadditions were carried out with
enol ether 5, nitroalkene 25, and the same dipolarophiles 26–
30.[18,19] We also included one example using 1-nitro-4-phenyl-
buta-1,3-diene (35) to achieve a pyrrolidine bearing a (4-phen-
ylbutyl)amine moiety instead of a (2-arylethyl)amine for biologi-
cal comparison. These cycloaddition reactions took place again
with complete regioselectivity and gave azonites 11–16 as mix-
tures of two or three diastereoisomers (Scheme 7, Table 3).
Clearly, the steroid and cyclopentane rings influence the 1,3-
cycloaddition reactions differently. Again in most cases, only
the major isomer (a) could be isolated in pure form. The cyclo-
additions of the electron-deficient dipolarophiles (Table 3, En-
tries 2, 4, and 6) resulted again in higher yields of the products.
Scheme 7. Multicomponent reactions of enol ether 5 to form azonites 11–
16.
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Stereochemical elucidation of azonites 11–16 was carried
out by comparison of their 1H and 13C NMR spectra with the
corresponding spectra of azinates 6–10. The hetero-Diels–Alder
cycloaddition of enol ether 5 and heterodienes 25 and 35 took
place through reaction on the bottom face of enol ether 5 as a
result of the presence of the -methyl group at C-13.[30] The
formation of isomers c of the steroid derivatives could be due
to the presence of the -methyl group at C-13. This methyl
group might force the methoxy group into a different confor-
mation, and at the same time this may change the conforma-
tion of the dihydrooxazine ring of azinates 31, placing the R2
group (Ph or PhCH=CH) away from the top face.
Finally, the target steroid-derived pyrrolidines were synthe-
sized by reduction of azonites 11a–16a under the same condi-
tions as before (Raney-Ni, MeOH, 23 °C) to give pyrrolidines
21a–24a in fair to good yields (Scheme 8, Table 4).[25] The re-
duction of azonites 14a and 15a did not provide the corre-
sponding pyrrolidines, but gave mixtures of unidentified com-
pounds. The stereochemistry at C-17 was determined by com-
parison of the coupling constants between 16-H and 17-H of
compounds 17a, 18a, and 20a (J = 7.0–8.2 Hz).[31]
Scheme 8. Reduction of azonites 11a–16a to form pyrrolidines 21a–24a.
Table 4. Synthesis of pyrrolidines 21a–24a.
Entry Azonite R1/R2 Product(s) R3 Yield [%]
1 11a Ph/Ph 21a Ph 54
2 12a CO2Me/Ph 22a CO2Me 62
3 13a CH(OCH2)2/Ph 23a CH(OCH2)2 81
4 14a CN/Ph – – –
5 15a OAc/Ph – – –
6 16a CO2Me/PhCH=CH 24a CO2Me 49[a]
[a] R2 is PhCH2CH2 after the reduction.
Conclusions
The realm of azasteroids is continuously expanding. New pyrrol-
idines fused to (acetyl-protected) dehydroepiandrosterone on
the D-ring can be synthesized in three steps, of which a high-
pressure-promoted multicomponent cycloaddition reaction is
the key step. The resulting model and steroidal compounds pre-
sented in this publication will be tested and their properties
evaluated to demonstrate the influence of the steroid part of
the molecules.
Experimental Section
General Methods: Commercially available chemicals were used
without purification. Solvents were distilled from appropriate drying
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agents before use and stored under nitrogen. Reactions were moni-
tored and Rf values obtained using thin-layer chromatography (TLC)
on silica-gel-coated plates (Merck 60 F254). TLC plates were visual-
ized with UV light and by charring at ca. 150 °C after dipping the
plate into a basic aqueous solution of KMnO4. Column or flash chro-
matography was carried out using Acros silica gel (0.035–0.070 mm,
pore diameter ca. 6 nm). NMR spectra were recorded with a Bruker
DMX 300 (300 MHz) or a Varian 400 (400 MHz) spectrometer in
CDCl3 solutions. Chemical shifts are given in parts per million (ppm),
with CHCl3 (δ = 7.26 ppm for 1H) and CDCl3 (δ = 77.16 ppm for
13C) used as internal standards. Coupling constants are reported as
J values in Hertz (Hz). Melting points were measured with a Reichert
Thermopan microscope.
General Procedure for the High-Pressure-Promoted Three-Com-
ponent Reactions: A flexible 7.5 mL PTFE tube was loaded with
enol ether 4 or 5, nitroalkene 25 or 35, dipolarophile 26–30, and
enough CH2Cl2 to fill up the 7.5 mL vessel. The reaction mixture
put under a pressure of 15 kbar at 23 °C for 18 h. After depressurisa-
tion, the reaction mixture was concentrated in vacuo, and the prod-
ucts were separated by column chromatography on silica gel.
(2R,3aR,4R,4aS,7aS)-7a-Methoxy-2,4-diphenyl-3,3a,4,4a,5,6,
7,7a-octahydro-2H-cyclopenta[e]isoxazolo[2,3-b][1,2]oxazine
(6a): Prepared according to the general procedure from enol ether
4 (300 mg, 3.06 mmol), nitroalkene 25 (400 mg, 2.68 mmol), and
dipolarophile 26 (462 μL, 420 mg, 4.04 mmol). This reaction gave
pure azonite 6a (564 mg, 60 %) as a white solid, and an impure
sample of azonite 6b (34 mg, 4 %) in a second fraction (total yield
64 %) after column chromatography (heptane/EtOAc, 9:1). 1H NMR
(300 MHz, CDCl3): δ = 7.37–7.20 (m, 10 H, 2 Ph), 5.68 (t, J = 7.8 Hz,
1 H, 2-H), 3.96 (td, J = 9.0, 6.3 Hz, 1 H, 3a-H), 3.46 (s, 3 H, OCH3),
2.63 (dd, J = 12.7, 8.9 Hz, 1 H, 4-H), 2.53–2.38 (m, 2 H), 2.30–2.05
(m, 2 H), 1.84–1.55 (m, 4 H), 1.25–1.11 (m, 1 H) ppm. 13C NMR
(75 MHz , CDCl3): δ = 141.0 (Phipso): δ = 139.2 (Phipso), 129.0, 128.6,
128.6, 128.2, 127.3, 126.6, 112.4 (C-7a), 84.4 (C-2), 74.8 (C-3a), 51.7
(CH3O), 49.5, 47.2, 41.3, 32.1, 28.9, 22.4 ppm. HRMS (ESI): calcd. for
C22H25NO3 [M + H]+ 352.19127; found 352.19134. M.p. 120–121 °C.
Methyl (2R,3aR,4R,4aS,7aS)-7a-Methoxy-4-phenyl-3,3a,4,4a,5,6,
7,7a-octahydro-2H-cyclopenta[e]isoxazolo[2,3-b][1,2]oxazine-2-
carboxylate (7a) and Methyl (2S,3aR,4R,4aS,7aS)-7a-Methoxy-4-
phenyl-3,3a,4,4a,5,6,7,7a-octahydro-2H-cyclopenta[e]isox-
azolo[2,3-b][1,2]oxazine-2-carboxylate (7b): Prepared according
to the general procedure from enol ether 4 (300 mg, 3.06 mmol),
nitroalkene 25 (400 mg, 2.68 mmol) and dipolarophile 27 (500 μL,
478 mg, 5.55 mmol). This reaction gave azonite 7a (540 mg, 60 %)
as a white solid, and azonite 7b (195 mg, 22 %) as an off-white solid
(total yield 82 %) after column chromatography (heptane/EtOAc,
4:1). Data for 7a: 1H NMR (300 MHz, CDCl3): δ = 7.39–7.20 (m, 5 H,
Ph), 5.11 (dd, J = 9.1, 5.3 Hz, 1 H, 2-H), 3.78 (q, J = 8.1 Hz, 1 H, 3a-
H), 3.72 (s, 3 H, CO2CH3), 3.42 (s, 3 H, OCH3), 2.59–2.34 (m, 4 H),
2.14–2.00 (m, 1 H), 1.81–1.54 (m, 4 H), 1.21–1.10 (m, 1 H) ppm. 13C
NMR (75 MHz, CDCl3): δ = 170.4 (CO2), 140.8 (Phipso), 129.0, 128.5,
127.4 (Phpara), 112.8 (C-7a), 80.6 (C-2), 73.5 (C-3a), 52.5 (CO2CH3),
51.5 (CH3O), 49.5, 47.1, 36.6, 31.8, 28.6, 22.2 ppm. HRMS (ESI): calcd.
for C18H23NO5 [M + H]+ 334.16545; found 334.16615. M.p. 109–
112 °C. Data for 7b: 1H NMR (300 MHz, CDCl3): δ = 7.39–7.20 (m, 5
H, Ph), 4.75 (dd, J = 9.0, 5.7 Hz, 1 H, 2-H), 3.81 (s, 3 H, CO2CH3), 3.70
(q, J = 8.2 Hz, 1 H, 3a-H), 3.42 (s, 3 H, OCH3), 2.68–2.34 (m, 4 H),
2.10–1.96 (m, 1 H), 1.81–1.48 (m, 4 H), 1.21–1.08 (m, 1 H) ppm. 13C
NMR (75 MHz, CDCl3): δ = 171.0 (CO2), 140.7 (Phipso), 128.6, 128.2,
127.0 (Phpara), 112.3 (C-7a), 80.9 (C-2), 73.9 (C-3a), 52.2 (CO2CH3),
50.9 (CH3O), 49.1, 46.7, 34.3, 31.3, 28.3, 21.8 ppm. HRMS (ESI): calcd.
for C18H23NO5 [M + H]+ 334.16545; found 334.16591. M.p. 88–91 °C.
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(2R,3aR,4R,4aS,7aS)-2-(1,3-Dioxolan-2-yl)-7a-methoxy-4-
phenyl-3,3a,4,4a,5,6,7,7a-octahydro-2H-cyclopenta[e]isox-
azolo[2,3-b][1,2]oxazine (8a): Prepared according to the general
procedure from enol ether 4 (300 mg, 3.06 mmol), nitroalkene 25
(400 mg, 2.68 mmol), and dipolarophile 28 (400 μL, 400 mg,
4.00 mmol). This reaction gave pure azonite 8a (350 mg, 38 %) as
a white solid, and a 3:1 mixture of azonites 8a and 8b (200 mg,
21 %) in a second fraction (total yield 59 %) after column chroma-
tography (heptane/EtOAc, 4:1). 1H NMR (300 MHz, CDCl3): δ = 7.38–
7.21 (m, 5 H, Ph), 4.89 (d, J = 3.8 Hz, 1 H, OCHO), 4.71 (ddd, J = 8.9,
5.1, 3.9 Hz, 1 H, 2-H), 4.03–3.91 (m, 2 H), 3.91–3.78 (m, 2 H), 3.72 (q,
J = 8.2 Hz, 1 H, 3a-H), 3.42 (s, 3 H, OCH3), 2.52 (dd, J = 12.8, 7.8 Hz,
1 H, 4-H), 2.42 (ddd, J = 12.8, 7.7, 3.6 Hz, 1 H, 4a-H), 2.29 (ddd, J =
12.2, 8.4, 5.1 Hz, 1 H, 3-H), 2.15 (dt, J = 12.2, 8.6 Hz, 1 H, 3-H), 2.10–
2.00 (m, 1 H), 1.81–1.53 (m, 4 H), 1.22–1.07 (m, 1 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 141.2 (Phipso), 128.9, 128.5, 127.2 (Phpara), 112.5
(C-7a), 103.2 (OCHO), 83.6 (C-2), 73.8 (C-3a), 65.5 (C-3′, C-4′), 52.0
(CH3O), 49.4, 47.0, 33.7, 31.7, 28.6, 22.2 ppm. HRMS (ESI): calcd. for
C19H25NO5 [M + Na]+ 370.16304; found 370.16355.
(2R,3aR,4R,4aS,7aS)-7a-Methoxy-4-phenyl-3,3a,4,4a,5,6,7,7a-oc-
tahydro-2H-cyclopenta[e]isoxazolo[2,3-b][1,2]oxazine-2-carbo-
nitrile (9a) and (2S,3aR,4R,4aS,7aS)-7a-Methoxy-4-phenyl-
3,3a,4,4a,5,6,7,7a-octahydro-2H-cyclopenta[e]isoxazolo[2,3-
b][1,2]oxazine-2-carbonitrile (9b): Prepared according to the gen-
eral procedure from enol ether 4 (300 mg, 3.06 mmol), nitroalkene
25 (400 mg, 2.68 mmol), and dipolarophile 29 (352 μL, 285 mg,
5.37 mmol). This reaction gave azonite 9a (336 mg, 42 %) as a white
solid, and azonite 9b (268 mg, 33 %) as a white solid (total yield
75 %) after column chromatography (heptane/EtOAc, 9:1). Data for
9a: 1H NMR (300 MHz, CDCl3): δ = 7.41–7.19 (m, 5 H, Ph), 5.20 (dd,
J = 9.0, 5.5 Hz, 1 H, 2-H), 3.89 (q, J = 8.0 Hz, 1 H, 3a-H), 3.41 (s, 3 H,
OCH3), 2.64 (ddd, J = 12.4, 8.2, 5.5 Hz, 1 H, 3-H), 2.52 (dd, J = 12.6,
8.2 Hz, 1 H, 4-H), 2.52 (dt, J = 12.5, 8.6 Hz, 1 H, 3-H), 2.42 (ddd, J =
12.6, 7.9, 3.6 Hz, 1 H, 4a-H), 2.15–2.00 (m, 1 H), 1.81–1.53 (m, 4 H),
1.22–1.09 (m, 1 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 140.0 (Phipso),
129.2, 128.4, 127.8 (Phpara), 116.7 (CN), 113.1 (C-7a), 74.3 (C-3a), 68.8
(C-2), 51.2 (CH3O), 49.6, 47.1, 38.0, 31.6, 28.5, 22.2 ppm. HRMS (ESI):
calcd. for C17H20N2O3 [M + H]+ 301.15522; found 301.15430. M.p.
138–141 °C. Data for 9b: 1H NMR (300 MHz, CDCl3): δ = 7.40–7.21
(m, 5 H, Ph), 4.92 (dd, J = 9.3, 5.2 Hz, 1 H, 2-H), 3.76 (q, J = 8.1 Hz,
1 H, 3a-H), 3.45 (s, 3 H, OCH3), 2.77 (ddd, J = 12.5, 9.5, 8.9 Hz, 1 H,
3-H), 2.70 (dd, J = 12.6, 8.2, Hz, 1 H, 4-H), 2.51 (ddd, J = 12.5, 7.5,
5.3 Hz, 1 H, 3-H), 2.39 (ddd, J = 12.6, 7.6, 3.2 Hz, 1 H, 4a-H), 2.18–
2.05 (m, 1 H), 1.82–1.53 (m, 4 H), 1.27–1.11 (m, 1 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 140.3 (Phipso), 129.2, 128.4, 127.7 (Phpara), 118.7
(CN), 113.2 (C-7a), 74.5 (C-3a), 68.6 (C-2), 51.3, 49.6, 47.4, 38.5, 31.6,
28.6, 22.2 ppm. HRMS (ESI): calcd. for C17H20N2O3 [M + H]+
301.15522; found 301.15454. M.p. 107–108 °C.
(2R,3aR,4R,4aS,7aS)-7a-Methoxy-4-phenyl-3,3a,4,4a,5,6,7,7a-oc-
tahydro-2H-cyclopenta[e]isoxazolo[2,3-b][1,2]oxazin-2-yl Acet-
ate (10a): Prepared according to the general procedure from enol
ether 4 (300 mg, 3.06 mmol), nitroalkene 25 (400 mg, 2.68 mmol),
and dipolarophile 30 (492 μL, 460 mg, 5.34 mmol). This reaction
gave pure azonite 10a (510 mg, 57 %) as a white solid, and an
impure sample of azonite 10b (90 mg, 10 %) in a second fraction
(total yield 67 %) after column chromatography (heptane/EtOAc,
7:3). 1H NMR (300 MHz, CDCl3): δ = 7.41–7.21 (m, 5 H, Ph), 6.73 (d,
J = 4.9 Hz, 1 H, 2-H), 3.80 (ddd, J = 10.8, 7.8, 6.3 Hz, 1 H, 3a-H), 3.42
(s, 3 H, OCH3), 2.58–2.47 (m, 2 H), 2.41 (ddd, J = 12.9, 10.8, 5.0 Hz,
1 H, 3-H), 2.32 (dd, J = 12.9, 6.4 Hz, 1 H), 2.16–2.00 (m, 1 H), 1.97 (s,
3 H, CH3CO), 1.81–1.54 (m, 4 H), 1.22–1.09 (m, 1 H). 13C NMR
(75 MHz, CDCl3): δ = 169.6 (CO2), 140.7 (Phipso), 129.1, 128.5, 127.5
(Phpara), 113.0 (C-7a), 99.4 (C-2), 70.6 (C-3a), 51.0 (CH3O), 49.5, 47.2,
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37.8, 31.5, 28.6, 22.3, 21.0 (CH3CO) ppm. HRMS (ESI): calcd. for
C18H23NO5 [M + Na]+ 356.14739; found 356.14773. M.p. 95–98 °C.
(3S,3′R,4′R,5′′R,16S,17R)-17-Methoxy-4′,5′′-diphenyl-3′,4′,4′′,5′′,
16,17-hexahydro[1,2]oxazolo[2′′,3′′:2′,3′]oxazino[5′,6′:16,17]an-
drost-5-en-3-yl Acetate (11a): Prepared according to the general
procedure from enol ether 5 (500 mg, 1.45 mmol), nitroalkene 25
(206 mg, 1.38 mmol), and dipolarophile 26 (317 μL, 288 mg,
2.77 mmol). This reaction gave pure azonite 11a (167 mg, 20 %) as
a white solid in one fraction, and a 3:1 mixture of azonites 11a and
11b (380 mg, 46 %) in a second fraction (total yield 66 %) after
column chromatography (PhMe/Et2O, 25:1). 1H NMR (400 MHz,
CDCl3): δ = 7.44–7.18 (m, 10 H, 2 Ph), 5.61 (dd, J = 9.0, 6.6 Hz, 1 H,
5′′-H), 5.36 (d, J = 4.8 Hz, 1 H, 6-H), 4.69–4.54 (m, 1 H, 3-H), 4.09 (td,
J = 8.8, 4.4 Hz, 1 H, 3′-H), 3.50 (s, 3 H, OCH3), 2.78 (t, J = 9.3 Hz, 1
H, 4′-H), 2.37 (ddd, J = 12.0, 6.5, 4.4 Hz, 1 H, 4′′-H), 2.35–2.28 (m, 2
H, 4-H2), 2.21 (dt, J = 12.1, 9.0 Hz, 1 H, 4′′-H), 2.25–2.17 (m, 1 H, 16-
H), 2.04 (s, 3 H, CH3CO), 1.99–1.82 (m, 4 H, 1-H + 2-H + 7-H + 12-
H), 1.77 (dt, J = 12.8, 3.0 Hz, 1 H, 12-H), 1.68–1.42 (m, 7 H, 2-H, 7-H,
8-H, 11-H2, 14-H, 15-H), 1.25 (dd, J = 11.9, 4.8 Hz, 1 H, 15-H), 1.21–
1.11 (m, 1 H, 1-H), 1.11–1.02 (m, 1 H, 9-H), 1.03 (s, 3 H, 19-CH3), 0.98
(s, 3 H, 18-CH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 170.7 (CO2),
143.2 (4′-Phipso), 140.1 (C-5), 138.2 (5′′-Phipso), 128.94, 128.90, 128.6,
128.4, 127.1, 126.9 (5′′-Phpara), 122.1 (C-6), 110.9 (C-17), 82.7 (C-5′′),
74.0 (C-3), 72.0 (C-3′), 51.4 (CH3O), 51.2 (C-14), 50.2 (C-4′), 49.8 (C-
9), 48.7 (C-13), 45.6 (C-16), 41.6 (C-4′′), 38.2 (C-4), 37.1 (C-1), 36.7 (C-
10), 33.8 (C-12), 31.7 (C-7), 31.4 (C-8), 31.1 (C-15), 27.9 (C-2), 21.6
(CH3CO), 20.8 (C-11), 19.3 (C-19), 14.2 (C-18) ppm. HRMS (ESI): calcd.
for C38H47NO5 [M + H]+ 598.35325; found 598.35351.
Methyl (3S,3′R,4′R,5′′R,16S,17R)-3-Acetoxy-17-methoxy-4′-
phenyl-3′,4′,4′′,5′′,16,17-hexahydro[1,2]oxazolo[2′′,3′′:2′,3′]ox-
azino[5′,6′:16,17]androst-5-ene-5′′-carboxylate (12a) and Methyl
(3S,3′R,4′R,5′′S,16S,17R)-3-Acetoxy-17-methoxy-4′-phenyl-3′,4′,
4′′,5′′,16,17-hexahydro[1,2]oxazolo[2′′,3′′:2′,3′]oxazino[5′,6′:
16,17]androst-5-ene-5′′-carboxylate (12b): Prepared according
to the general procedure from enol ether 5 (500 mg, 1.45 mmol),
nitroalkene 25 (205 mg, 1.38 mmol), and dipolarophile 27 (300 μL,
287 mg, 3.33 mmol). This reaction gave azonite 12a (310 mg, 39 %)
as a white solid, azonite 12b (45 mg, 6 %) as a white solid, and a
2:3 mixture of azonites 12b and 12c (188 mg, 23 %; total yield 68 %)
after column chromatography (PhMe/Et2O, 25:1). Data for 12a: 1H
NMR (300 MHz, CDCl3): δ = 7.36–7.18 (m, 5 H, Ph), 5.36 (d, J =
4.8 Hz, 1 H, 6-H), 5.08 (t, J = 7.5 Hz, 1 H, 5′′-H), 4.68–4.53 (m, 1 H,
3-H), 3.88 (q, J = 7.5 Hz, 1 H, 3′-H), 3.76 (s, 3 H, CO2CH3), 3.46 (s, 3
H, OCH3), 2.81 (t, J = 7.0 Hz, 1 H, 4′-H), 2.42 (t, J = 7.6 Hz, 2 H), 2.41–
2.12 (m, 3 H), 2.04 (s, 3 H, CH3CO), 1.99–1.79 (m, 4 H), 1.77–1.42 (m,
8 H), 1.32–1.22 (m, 1 H), 1.21–1.08 (m, 1 H), 1.07–1.02 (m, 1 H), 1.02
(s, 3 H, 19-CH3), 0.93 (s, 3 H, 18-CH3) ppm. 13C NMR (75 MHz, CDCl3):
δ = 170.7 (CO2), 170.3 (CO2), 143.7 (Phipso), 140.1 (C-5), 128.9, 128.7,
127.1 (Phpara), 122.0 (C-6), 111.4 (C-17), 78.8 (C-5′′), 74.0 (C-3), 70.4
(C-3′), 52.6, 51.2, 49.8, 49.3, 48.7, 44.3, 38.2, 37.1, 36.7, 36.4, 33.4 (C-
12), 32.1, 31.6, 31.5, 27.8 (C-2), 21.6 (CH3CO), 20.7 (C-11), 19.3 (C-19),
14.1 (C-18) ppm. HRMS (ESI): calcd. for C34H45NO7 [M + H]+
580.32743; found 580.32719. Data for 12b: 1H NMR (300 MHz,
CDCl3): δ = 7.43–7.17 (m, 5 H, Ph), 5.36 (d, J = 4.2 Hz, 1 H, 6-H), 4.79
(dd, J = 9.0, 5.1 Hz, 1 H, 5′′-H), 4.68–4.53 (m, 1 H, 3-H), 3.84 (s, 3 H,
CO2CH3), 3.71 (td, J = 8.4, 4.8 Hz, 1 H, 3′-H), 3.46 (s, 3 H, OCH3), 3.04
(t, J = 5.1 Hz, 1 H, 4′-H), 2.67 (ddd, J = 12.9, 8.4, 5.2 Hz, 1 H, 4′′-H),
2.48 (dt, J = 12.1, 8.8 Hz, 1 H, 4′′-H), 2.41–2.27 (m, 2 H), 2.22–2.09
(m, 1 H), 2.04 (s, 3 H, CH3CO), 1.99–1.79 (m, 4 H), 1.77–1.42 (m, 8
H), 1.32–1.22 (m, 1 H), 1.21–1.08 (m, 1 H), 1.01 (s, 3 H, 19-CH3), 1.03–
0.89 (m, 1 H), 0.89 (s, 3 H, 18-CH3) ppm. 13C NMR (75 MHz, CDCl3):
δ = 171.6 (CO2), 170.6 (CO2), 144.9 (Phipso), 139.9 (C-5), 128.7, 128.5,
126.8 (Phpara), 122.3 (C-6), 111.6 (C-17), 79.6 (C-5′′), 73.9 (C-3), 70.4
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(C-3′), 52.7, 50.9, 50.3, 50.1, 48.7, 48.4, 42.5, 38.2, 37.1, 36.6, 33.6,
33.1, 32.7, 31.6, 31.5, 27.8 (C-2), 21.5 (CH3CO), 20.7 (C-11), 19.3 (C-
19), 13.9 (C-18) ppm. HRMS (ESI): calcd. for C34H45NO7 [M + H]+
580.32743; found 580.32737.
(3S,3′R,4′R,5′′R,16S,17R)-5′′-(1,3-Dioxolan-2-yl)-17-methoxy-4′-
phenyl-3′,4′,4′′,5′′,16,17-hexahydro[1,2]oxazolo[2′′,3′′:2′,3′]ox-
azino[5′,6′:16,17]androst-5-en-3-yl Acetate (13a): Prepared ac-
cording to the general procedure from enol ether 5 (550 mg,
1.60 mmol), nitroalkene 25 (220 mg, 1.48 mmol) and dipolarophile
28 (220 μL, 220 mg, 2.20 mmol). This reaction gave azonite 13a
(265 mg, 30 %) as a white solid, and a 1:6 mixture of azonites 13a/
13b (94 mg, 11 %) in a second fraction (total yield 41 %) after col-
umn chromatography (heptane/EtOAc, 6:1). 1H NMR (300 MHz,
CDCl3): δ = 7.38–7.18 (m, 5 H, Ph), 5.35 (d, J = 4.8 Hz, 1 H, 6-H), 4.96
(d, J = 4.2 Hz, 1 H, OCHO), 4.70–4.53 (m, 2 H, 3-H, 5′′-H), 4.06–3.94
(m, 2 H), 3.94–3.81 (m, 2 H), 3.79 (td, J = 7.8, 6.6 Hz, 1 H, 3′-H), 3.46
(s, 3 H, OCH3), 2.82 (t, J = 6.4 Hz, 1 H, 4′-H), 2.37–2.09 (m, 5 H), 2.04
(s, 3 H, CH3CO), 1.99–1.79 (m, 4 H), 1.76–1.42 (m, 8 H), 1.32–1.22 (m,
1 H), 1.21–1.05 (m, 1 H), 1.03–0.97 (m, 1 H), 1.01 (s, 3 H, 19-CH3),
0.92 (s, 3 H, 18-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.5 (CO2),
144.3 (Phipso), 140.0 (C-5), 128.7, 128.6, 126.8 (Phpara), 122.0 (C-6),
111.1 (C-17), 103.2 (OCHO), 81.7 (C-5′′), 73.9 (C-3), 70.4 (C-3′), 65.5
(2 ×), 51.0 (2 ×), 49.7, 49.5, 48.7, 44.0, 38.1, 37.0, 36.6, 33.3 (2 ×),
32.2, 31.5, 31.4, 27.7 (C-2), 21.4 (CH3CO), 20.6 (C-11), 19.3 (C-19), 14.0
(C-18) ppm. HRMS (ESI): calcd. for C35H47NO7 [M + H]+ 594.34308;
found 594.34197.
(3S,3′R,4′R,5′′R,16S,17R)-5′′-Cyano-17-methoxy-4′-phenyl-3′,4′,
4′′,5′′,16,17-hexahydro[1,2]oxazolo[2′′,3′′:2′,3′]oxazino[5′,6′
:16,17]androst-5-en-3-yl Acetate (14a), (3S,3′R,4′R,5′′S,16S,17R)-
5′′-Cyano-17-methoxy-4′-phenyl-3′,4′,4′′,5′′,16,17-hexa-
hydro[1,2]oxazolo[2′′,3′′:2′,3′]oxazino[5′,6′:16,17]androst-5-en-
3-yl Acetate (14b), and (3S,3′S,4′R,5′′S,16S,17R)-5′′-Cyano-17-
methoxy-4′-phenyl-3′,4′,4′′,5′′,16,17-hexahydro[1,2]oxazolo-
[2′′,3′′:2′,3′]oxazino[5′,6′:16,17]androst-5-en-3-yl acetate (14c):
Prepared according to the general procedure from enol ether 5
(500 g, 1.45 mmol), nitroalkene 25 (200 mg, 1.34 mmol), and di-
polarophile 29 (179 μL, 145 mg, 2.73 mmol). This reaction gave
azonite 14a (250 mg, 34 %) as a white solid, azonite 14b (190 mg,
26 %) as a white solid, and azonite 14c (137 mg, 19 %) as a white
solid (total yield 79 %) after column chromatography (heptane/
EtOAc, 6:1). Data for 14a: 1H NMR (300 MHz, CDCl3): δ = 7.35–7.20
(m, 5 H, Ph), 5.35 (d, J = 4.5 Hz, 1 H, 6-H), 5.15 (dd, J = 8.1, 6.6 Hz,
1 H, 5′′-H), 4.68–4.53 (m, 1 H, 3-H), 3.94 (td, J = 7.8, 6.6 Hz, 1 H, 3′-
H), 3.45 (s, 3 H, OCH3), 2.81 (dd, J = 7.2, 6.3 Hz, 1 H, 4′-H), 2.65–2.46
(m, 2 H), 2.37–2.14 (m, 3 H), 2.04 (s, 3 H, CH3CO), 1.96–1.42 (m, 12
H), 1.32–1.22 (m, 1 H), 1.21–1.05 (m, 1 H), 1.04–0.97 (m, 1 H), 1.01
(s, 3 H, 19-CH3), 0.93 (s, 3 H, 18-CH3) ppm. 13C NMR (75 MHz, CDCl3):
δ = 170.7 (CO2), 143.2 (Phipso), 140.1 (C-5), 129.1, 128.5, 127.4
(Phpara), 121.9 (C-6), 116.7 (CN), 111.9 (C-17), 73.9 (C-3), 70.8, 67.1,
51.3, 51.1, 49.8, 49.0, 48.7, 44.1, 38.2, 37.6, 37.1, 36.7, 33.3, 32.2, 31.6,
31.5, 27.8 (C-2), 21.5 (CH3CO), 20.7 (C-11), 19.3 (C-19), 14.1 (C-18)
ppm. HRMS (ESI): calcd. for C33H42N2O5 [M + H]+ 547.31720; found
547.31760. Data for 14b: 1H NMR (300 MHz, CDCl3): δ = 7.40–7.19
(m, 5 H, Ph), 5.35 (d, J = 5.1 Hz, 1 H, 6-H), 4.92 (dd, J = 8.2, 4.6 Hz,
1 H, 5′′-H), 4.66–4.52 (m, 1 H, 3-H), 3.78 (td, J = 8.1, 5.4 Hz, 1 H, 3′-
H), 3.49 (s, 3 H, OCH3), 3.07 (t, J = 5.8 Hz, 1 H, 4′-H), 2.70 (dt, J =
12.3, 8.8 Hz, 1 H, 4′′-H), 2.54 (ddd, J = 12.3, 7.5, 4.5 Hz, 1 H, 4′′-H),
2.40–2.14 (m, 3 H), 2.03 (s, 3 H, CH3CO), 2.03–0.90 (m, 15 H), 1.01 (s,
3 H, 19-CH3), 0.94 (s, 3 H, 18-CH3) ppm. 13C NMR (75 MHz, CDCl3):
δ = 170.5 (CO2), 143.9 (Phipso), 140.1 (C-5), 128.9, 128.4, 127.2
(Phpara), 122.0 (C-6), 118.9 (CN), 112.3 (C-17), 74.0 (C-3), 71.0, 67.1,
51.1, 50.7, 49.4, 48.9, 48.8, 43.2, 38.2, 37.5, 36.9, 36.7, 32.8, 31.7, 31.6,
27.8 (C-2), 21.5 (CH3CO), 20.7 (C-11), 19.4 (C-19), 13.9 (C-18) ppm.
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HRMS (ESI): calcd. for C33H42N2O5 [M + H]+ 547.31720; found
547.32008. Data for 14c: 1H NMR (300 MHz, CDCl3): δ = 7.42–7.19
(m, 5 H, Ph), 5.31 (d, J = 4.8 Hz, 1 H, 6-H), 4.95 (dd, J = 9.4, 2.2 Hz,
1 H, 5′′-H), 4.67–4.53 (m, 1 H, 3-H), 4.14 (ddd, J = 11.7, 5.2, 3.9 Hz,
1 H, 3′-H), 3.40 (s, 3 H, OCH3), 3.37 (td, J = 11.7, 9.4 Hz, 1 H), 2.99
(dd, J = 11.8, 3.3 Hz, 1 H), 2.64 (dd, J = 11.8, 6.6 Hz, 1 H), 2.42–2.15
(m, 3 H), 2.02 (s, 3 H, CH3CO), 2.03–1.94 (m, 1 H), 1.92–1.75 (m, 3
H), 1.73–1.33 (m, 8 H), 1.26–1.08 (m, 2 H), 1.07–1.00 (m, 1 H), 1.01
(s, 6 H, 18-CH3, 19-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.6
(CO2), 139.8, 139.2, 129.3, 128.2, 127.9 (Phpara), 122.1 (C-6), 118.2
(CN), 112.6 (C-17), 73.9 (C-3), 68.2, 67.6, 51.5, 49.8, 49.5, 49.3, 43.9,
40.2, 38.1, 37.0, 36.6, 35.3, 32.8, 31.6, 31.6, 31.5, 27.8 (C-2), 21.5
(CH3CO), 20.7 (C-11), 19.4 (C-19), 13.8 (C-18) ppm. HRMS (ESI): calcd.
for C33H42N2O5 [M + H]+ 547.31720; found 547.31584.
(3S,3′R,4′R,5′′R,16S,17R)-17-Methoxy-4′-phenyl-3′,4′,4′′,5′′,
16,17-hexahydro[1,2]oxazolo[2′′,3′′:2′,3′]oxazino[5′,6′:16,17]an-
drost-5-en-3,5 ′ ′-diyl Diacetate (15a) and (3S ,3 ′S ,4 ′R ,5 ′ ′
S,16S,17R)-17-Methoxy-4′-phenyl-3′,4′,4′′,5′′,16,17-hexa-
hydro[1 ,2 ]oxazolo[2 ′ ′ ,3 ′ ′ :2 ′ ,3 ′ ]oxaz ino[5 ′ , 6 ′ :16 ,17 ] -
androst-5-en-3,5′′-diyl Diacetate (15c): Prepared according to the
general procedure from enol ether 5 (500 mg, 1.45 mmol), nitroalk-
ene 25 (205 mg, 1.38 mmol), and 30 (267 μL, 255 mg, 2.96 mmol).
This reaction gave a 5:1 mixture of azonites 15a and 15c (428 mg,
54 %) as a white solid after column chromatography (heptane/
EtOAc, 6:1). The mixture was not further purified, because reduction
with Raney nickel in the next step did not lead to any identifiable
product. 1H NMR (300 MHz, CDCl3): δ = 7.39–7.20 (m, 5 H, Ph), 6.65
and 6.49 (2 d, J = 5.2 and 5.5 Hz, 1 H, 5′′-H), 5.36–5.30 (m, 1 H, 6-
H), 4.68–4.50 (m, 1 H, 3-H), 4.09–3.99 and 3.88 (m and dt, J = 9.6,
6.9 Hz, 1 H, 3′-H), 3.45 and 3.42 (2 s, 3 H, OCH3), 3.32–3.22 (m, 1/6
H), 2.96 (dd, J = 11.8, 3.5 Hz, 1/6 H), 2.70 (dd, J = 8.7, 6.6 Hz, 5/6 H,
4′-H), 2.67–2.57 (m, 1/6 H), 2.48–2.12 (m, 4 H), 2.03 and 2.02 (2 s, 3
H, CH3CO), 2.00 and 1.96 (2 s, 3 H, CH3CO), 1.99–1.79 (m, 4 H), 1.77–
1.42 (m, 8 H), 1.30–1.00 (m, 3 H), 1.00 and 0.98 (2 s, 3 H, 19-CH3),
0.97 and 0.94 (2 s, 3 H, 18-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ =
170.6 (CO2), 170.1 (CO2), 169.8 (CO2), 143.2, 140.0, 139.8, 129.1,
128.9, 128.6, 128.4, 127.6 (Phpara), 127.2 (Phpara), 122.1 (C-6), 122.0
(C-6), 112.6 (C-17), 112.0 (C-17), 97.6 (C-5′′), 97.5 (C-5′′), 73.9 (C-3),
67.2 (C-3′), 65.4 (C-3′), 51.7, 51.3, 51.0, 49.7, 49.4, 49.3, 48.5, 45.6,
43.8, 40.6, 38.2, 38.2, 37.0, 36.7, 36.6, 35.6, 33.4, 32.6, 31.6, 31.5, 31.4,
27.8 (C-2), 21.5, 21.3, 21.1, 20.7, 19.3 (C-19), 14.1 (C-18), 13.7 (C-18)
ppm. HRMS (ESI): calcd. for C34H45NO7 [M + Na]+ 602.30937; found
602.30904.
Methyl (3S,3′R,4′S,5′′R,16S,17R)-3-Acetoxy-17-methoxy-4′-(2-
phenylethyl)-3′,4′,4′′,5′′,16,17-hexahydro[1,2]oxazolo[2′′,3′′:
2′,3′]oxazino[5′,6′:16,17]androst-5-ene-5′′-carboxylate (16a):
Prepared according to the general procedure from enol ether 5
(550 mg, 1.60 mmol), nitroalkene 35 (650 mg, 3.71 mmol), and di-
polarophile 27 (400 μL, 382 mg, 4.44 mmol). This reaction gave
azonite 16a (281 mg, 29 %) as a white solid, and a 2:7 mixture of
azonites 16b and 16c (407 mg, 42 %) in a second fraction (total
yield 71 %) after column chromatography (heptane/EtOAc, 5:1). 1H
NMR (300 MHz, CDCl3): δ = 7.40–7.17 (m, 5 H, Ph), 6.42–6.32 (m, 2
H, CH=CH), 5.36 (d, J = 4.7 Hz, 1 H, 6-H), 5.05 (dd, J = 8.4, 6.0 Hz, 1
H, 5′′-H), 4.68–4.53 (m, 1 H, 3-H), 3.78 (s, 3 H, CO2CH3), 3.62 (td, J =
8.4, 4.8 Hz, 1 H, 3′-H), 3.45 (s, 3 H, OCH3), 2.63–2.39 (m, 3 H), 2.38–
2.24 (m, 2 H), 2.04 (s, 3 H, CH3CO), 2.03–1.78 (m, 5 H), 1.77–1.34 (m,
9 H), 1.20–1.08 (m, 1 H), 1.02 (s, 3 H, 19-CH3), 1.04–0.95 (m, 1 H),
0.93 (s, 3 H, 18-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.6 (CO2),
170.5 (CO2), 140.1 (C-5), 137.0 (Phipso), 133.1, 130.5, 128.6, 127.5
(Phpara), 124.4, 122.0 (C-6), 111.5 (C-17), 79.3 (C-5′′), 73.9 (C-3), 69.3
(C-3′), 52.6, 51.1, 50.9, 49.8, 48.9, 45.4, 41.1, 38.2, 37.0, 36.7, 34.7 (C-
12), 32.8, 31.8, 31.6, 27.8 (C-2), 21.5 (CH3CO), 20.6 (C-11), 19.3 (C-19),
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13.9 (C-18) ppm. HRMS (ESI): calcd. for C36H47NO7 [M + H]+
606.34308; found 606.34201.
General Procedure for the Raney-Nickel-Catalysed Reduction of
Compounds 6a–16a: Azonites 6a–16a (ca. 0.5 mmol) were dis-
solved in MeOH (60 mL) containing Et3N (8 drops). Raney nickel
(0.5–1.5 g; wet, washed with MeOH) was added, and the reaction
mixture was stirred in a stainless steel autoclave at 50 atm for 4 d.
After depressurisation and evaporation of the MeOH, the residue
was dissolved in CH2Cl2, and the solution was washed with water
(2 × 10 mL). The solution was then dried (Na2SO4), filtered, and
concentrated. The residue was purified by column chromatography
on silica gel.
(R)-1-Phenyl-2-[(2R,3R,3aS,6aS)-3-phenyl-1,2,3,3a,4,5,6,6a-octa-
hydrocyclopenta[b]pyrrol-2-yl]ethan-1-ol (17a): According to the
general procedure, azinate 6a (300 mg, 0.85 mmol) gave pyrrolidine
17a (195 mg, 74 %) as a white solid after column chromatography
(CHCl3/MeOH, 97:3, mixed in a 99:1 ratio with a 7 N solution of NH3
in MeOH). 1H NMR (300 MHz, CDCl3): δ = 7.37–7.13 (m, 10 H, 2 Ph),
5.15 (dd, J = 10.2, 2.8 Hz, 1 H, 1-H), 4.24 (br. s, 2 H, OH, NH), 3.83 (t,
J = 7.0 Hz, 1 H, 6a′-H), 3.55–3.45 (m, 1 H, 2′-H), 2.79–2.61 (m, 2 H,
3′-H, 3a′-H), 1.91–1.38 (m, 8 H) ppm. 13C NMR (75 MHz, CDCl3): δ =
145.2 (Phipso), 141.8 (Phipso), 128.8, 128.2, 128.1, 126.9 (Phpara), 126.8
(Phpara), 125.5, 71.4, 64.9, 61.9, 55.3, 52.1, 38.3, 34.9, 31.8, 23.7 ppm.
HRMS (ESI): calcd. for C21H25NO [M + H]+ 308.20144; found
308.20141.
Methyl (R)-2-Hydroxy-3-[(2R,3R,3aS,6aS)-3-phenyl-1,2,3,3a,4,5,
6,6a-octahydrocyclopenta[b]pyrrol-2-yl]propanoate (18a) and
(3aS,6R,7aR,8R,8aS)-6-Hydroxy-8-phenyl-2,3,3a,6,7,7a,8,8a-
octahydrocyclopenta[b]pyrrolizin-5(1H)-one (34a): According to
the general procedure, azinate 7a (600 mg, 1.80 mmol) gave pyrrol-
idine 18a (212 mg, 41 %) as a white solid, and pyrrolizidinone 34a
(244 mg, 53 %) after column chromatography (CHCl3/MeOH, 96:4,
mixed in a 99:1 ratio with a 7 N solution of NH3 in MeOH). Data for
18a: 1H NMR (300 MHz, CDCl3): δ = 7.37–7.17 (m, 5 H, Ph), 4.53 (dd,
J = 9.4, 3.6 Hz, 1 H, 2-H), 3.82 (dd, J = 8.1, 6.5 Hz, 1 H, 6a′-H), 3.70
(s, 3 H, CO2CH3), 3.39 (ddd, J = 10.6, 6.2, 3.0 Hz, 1 H, 2′-H), 2.65 (q,
J = 7.9 Hz, 1 H, 3a′-H), 2.46 (dd, J = 10.2, 9.1 Hz, 1 H, 3′-H), 1.88–
1.39 (m, 8 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 174.7 (CO2), 141.6
(Phipso), 128.8, 128.0, 126.8 (Phpara), 69.5, 64.1, 62.3, 57.1, 52.4, 52.1,
34.8, 34.0, 31.7, 23.6 ppm. HRMS (ESI): calcd. for C17H23NO3 [M +
H]+ 290.17562; found 290.17606. Data for 34a: 1H NMR (300 MHz,
CDCl3): δ = 7.40–7.19 (m, 5 H, Ph), 4.54 (dd, J = 9.5, 8.5 Hz, 1 H),
4.23 (br. s, 1 H, OH), 4.14–4.06 (m, 1 H), 3.82 (td, J = 9.4, 5.4 Hz, 1
H), 3.15–3.02 (m, 1 H), 2.56 (ddd, J = 12.4, 7.4, 5.4 Hz, 1 H), 2.56–
2.44 (m, 1 H), 2.44 (t, J = 10.1 Hz, 1 H), 1.90–1.49 (m, 6 H) ppm. 13C
NMR (75 MHz, CDCl3): δ = 172.2 (CON), 139.0 (Phipso), 128.9, 127.7,
127.4 (Phpara), 74.4, 65.0, 59.5, 57.1, 55.0, 36.7, 29.9, 29.6, 24.4 ppm.
HRMS (ESI): calcd. for C16H19NO2 [M + H]+ 258.14940; found
258.14950.
(R)-1-(1,3-Dioxolan-2-yl)-2-[(2R,3R,3aS,6aS)-3-phenyl-1,2,3,3a,4,
5,6,6a-octahydrocyclopenta[b]pyrrol-2-yl]ethan-1-ol (19a): Ac-
cording to the general procedure, azinate 8a (250 mg, 0.72 mmol)
gave pyrrolidine 19a (145 mg, 66 %) as a white solid after column
chromatography (CHCl3/MeOH, 98:2, mixed in a 99:1 ratio with a
7 N solution of NH3 in MeOH). 1H NMR (300 MHz, CDCl3): δ = 7.35–
7.17 (m, 5 H, Ph), 4.70 (d, J = 3.4 Hz, 1 H, OCHO), 4.05 (dt, J = 10.8,
3.4 Hz, 1 H, 1-H), 4.00–3.90 (m, 2 H), 3.90–3.77 (m, 3 H), 3.54 (ddd,
J = 10.3, 5.1, 1.8 Hz, 1 H, 2′-H), 2.66 (q, J = 7.8 Hz, 1 H, 3a′-H), 2.56
(dd, J = 10.2, 9.0 Hz, 1 H, 3′-H), 1.85–1.32 (m, 8 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 142.0 (Phipso), 128.7, 128.1, 126.7 (Phpara), 105.8
(OCHO), 69.9, 65.4, 65.4, 64.3, 61.7, 55.6, 52.4, 35.1, 31.8, 30.4,
Eur. J. Org. Chem. 2017, 3729–3737 www.eurjoc.org © 2017 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim3735
23.6 ppm. HRMS (ESI): calcd. for C18H25NO3 [M + H]+ 304.19127;
found 304.19133.
(R)-1-Acetamido-3-[(2R,3R,3aS,6aS)-1-acetyl-3-phenyl-1,2,3,3a,
4,5,6,6a-octahydrocyclopenta[b]pyrrol-2-yl]propan-2-yl Acetate
(20a): The residue formed after having applied the general proce-
dure with azinate 9a (200 mg, 0.67 mmol) was dissolved in Ac2O
(6 mL) and pyridine (2 drops). The resulting mixture was stirred at
23 °C for 3 d. The solvent was then evaporated to dryness under
high vacuum. Purification by column chromatography (CHCl3/
MeOH, 98:2→ 97:3) gave pyrrolidine 20a (144 mg, 56 %) as a white
solid. 1H NMR (300 MHz, CDCl3): δ = 7.36–7.19 (m, 5 H, Ph), 7.05 (br.
s, 1 H, NH), 4.78–4.68 (m, 1 H), 4.36 (td, J = 8.2, 3.5 Hz, 1 H), 4.02
(ddd, J = 9.2, 6.5, 2.4 Hz, 1 H), 3.64 (ddd, J = 14.8, 7.8, 3.3 Hz, 1 H),
2.94 (t, J = 6.8 Hz, 1 H), 2.87 (dt, J = 14.8, 4.2 Hz, 1 H), 2.75 (qd, J =
7.8, 3.4 Hz, 1 H), 2.32 (ddd, J = 13.5, 9.4, 2.5 Hz, 1 H), 2.17 (s, 3 H,
CH3CO), 2.21–2.07 (m, 1 H), 1.98 (s, 3 H, CH3CO), 1.91 (s, 3 H, CH3CO),
1.99–1.60 (m, 4 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.7 (CO),
170.6 (CO), 170.0 (CO), 142.9 (Phipso), 129.1, 127.2, 70.3, 65.5, 63.9,
57.2, 53.0, 40.7, 37.6, 34.5, 30.7, 24.6, 23.2, 22.9, 21.2 ppm. HRMS
(ESI): calcd. for C21H28N2O4 [M + Na]+ 409.21033; found 409.21086.
(3S,4′R,5′R,16S,17R)-5′-[(2R)-2-Hydroxy-2-phenylethyl]-4′-
phenyl-4′,5′,16,17-tetrahydro-1′H-pyrrolo[3′,2′:16,17]androst-5-
en-3-yl Acetate (21a): According to the general procedure, azinate
11a (300 mg, 0.50 mmol) gave pyrrolidine 21a (149 mg, 54 %) as a
white solid after column chromatography (CHCl3, mixed in a 99:1
ratio with a 7 N solution of NH3 in MeOH). 1H NMR (300 MHz, CDCl3):
δ = 7.39–7.13 (m, 10 H, 2 Ph), 5.38 (d, J = 4.8 Hz, 1 H, 6-H), 5.20 (dd,
J = 10.6, 2.6 Hz, 1 H, 2′′-H), 4.65–4.51 (m, 1 H, 3-H), 3.49 (dt, J =
10.0, 3.3 Hz, 1 H, 5′-H), 3.32 (d, J = 7.5 Hz, 1 H, 17-H), 2.83–2.70 (m,
2 H, 16-H, 4′-H), 2.40–2.21 (m, 2 H), 2.02 (s, 3 H, CH3CO), 2.01–1.33
(m, 17 H), 1.24–1.00 (m, 2 H), 1.03 (s, 3 H, 19-CH3), 0.76 (s, 3 H, 18-
CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.6 (CO2), 145.0 (Phipso),
142.2 (Phipso), 139.7 (C-5), 128.8, 128.2, 128.2, 127.0 (Phpara), 126.9
(Phpara), 125.6, 122.6 (C-6), 74.1 (C-3), 71.4, 71.0, 65.2, 55.2, 49.7, 49.5,
48.3, 43.6, 38.2, 37.8, 37.0, 36.8, 33.3, 32.9, 32.4, 31.6, 27.9 (C-2), 21.6
(CH3CO), 20.6 (C-11), 19.5 (C-19), 18.9 (C-18) ppm. HRMS (ESI): calcd.
for C37H47NO3 [M + H]+ 554.36342; found 554.36350.
Methyl (2R)-3-{(3S,4′R,5′R,16S,17R)-3-Acetoxy-4′-phenyl-4′,5′,
16,17-tetrahydro-1′H-pyrrolo[3′,2′:16,17]androst-5-en-5′-yl}-2-
hydroxypropanoate (22a): According to the general procedure,
azinate 12a (250 mg, 0.43 mmol) gave pyrrolidine 22a (143 mg,
62 %) as a white solid after column chromatography (CHCl3/MeOH,
96:4). 1H NMR (300 MHz, CDCl3): δ = 7.38–7.19 (m, 5 H, Ph), 5.38 (d,
J = 5.4 Hz, 1 H, 6′-H), 4.62 (dd, J = 9.5, 4.1 Hz, 1 H, 2-H), 4.67–4.54
(m, 1 H, 3′-H), 3.69 (s, 3 H, CO2CH3), 3.56–3.46 (m, 1 H, 5′′-H), 3.38
(d, J = 8.1 Hz, 1 H, 17′-H), 2.72 (q, J = 7.9 Hz, 1 H, 16′-H), 2.54 (dd,
J = 10.6, 8.2 Hz, 1 H, 4′′-H), 2.40–2.23 (m, 2 H), 2.03 (s, 3 H, CH3CO),
1.99–1.34 (m, 17 H), 1.21–1.00 (m, 2 H), 1.02 (s, 3 H, 19′-CH3), 0.76
(s, 3 H, 18′-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 174.3 (CO2),
170.6 (CO2), 141.2 (Phipso), 139.7 (C-5′), 128.9, 128.0, 127.1 (Phpara),
122.4 (C-6′), 74.0 (C-3′), 71.2, 69.2, 64.1, 56.2, 52.3, 49.7, 49.4, 48.2,
43.4, 38.2, 37.0, 36.8, 33.2, 32.6, 32.4, 31.5, 27.8 (C-2′), 21.5 (CH3CO),
20.5 (C-11′), 19.4 (C-19′), 18.7 (C-18′) ppm. HRMS (ESI): calcd. for
C33H45NO5 [M + H]+ 536.33760; found 536.33904.
(3S,4′R,5′R,16S,17R)-5′-[(2R)-2-(1,3-Dioxan-2-yl)-2-hydroxy-
ethyl]-4′-phenyl-4′,5′,16,17-tetrahydro-1′H-pyrrolo[3′,2′:16,17]-
androst-5-en-3-yl Acetate (23a): According to the general proce-
dure, azinate 13a (315 mg, 0.53 mmol) gave pyrrolidine 23a
(235 mg, 81 %) as a white solid after column chromatography
(CHCl3, mixed in a 99:1 ratio with a 7 N solution of NH3 in MeOH).
1H NMR (300 MHz, CDCl3): δ =7.35–7.16 (m, 5 H, Ph), 5.38 (d, J =
4.8 Hz, 1 H, 6-H), 4.69 (d, J = 3.4 Hz, 1 H, OCHO), 4.67–4.52 (m, 1 H,
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3-H), 4.11 (dt, J = 11.5, 3.4 Hz, 1 H, 2′′-H), 4.02–3.93 (m, 2 H), 3.90–
3.81 (m, 2 H), 3.53 (dt, J = 10.8, 3.6 Hz, 1 H, 5′-H), 3.27 (d, J = 8.1 Hz,
1 H, 17-H), 2.69 (q, J = 8.0 Hz, 1 H, 16-H), 2.57 (dd, J = 10.4, 8.0 Hz,
1 H, 4′-H), 2.37–2.22 (m, 2 H), 2.03 (s, 3 H, CH3CO), 2.00–1.31 (m, 17
H), 1.19–1.01 (m, 2 H), 1.01 (s, 3 H, 19-CH3), 0.73 (s, 3 H, 18-CH3)
ppm. 13C NMR (75 MHz, CDCl3): δ = 170.5 (CO2), 142.0 (Phipso), 139.5
(C-5), 128.7, 128.1, 126.7 (Phpara), 122.5 (C-6), 105.7 (OCHO), 74.1 (C-
3), 70.8, 69.6, 65.3, 65.3, 64.4, 55.3, 49.6, 49.5, 48.0, 43.4, 38.1, 37.0,
36.7, 33.1, 32.7, 32.2, 31.5, 29.4, 27.8 (C-2), 21.5 (CH3CO), 20.5 (C-11),
19.4 (C-19), 18.8 (C-18) ppm. HRMS (ESI): calcd. for C34H47NO5 [M +
H]+ 550.35325; found 550.35295.
Methyl (2R)-3-{(3S,4′S,5′R,16S,17R)-3-Acetoxy-4′-(2-phenyl-
ethyl)-4′,5′,16,17-tetrahydro-1′H-pyrrolo[3′,2′:16,17]androst-5-
en-5′-yl}-2-hydroxypropanoate (24a): According to the general
procedure, azinate 16a (350 mg, 0.58 mmol) gave pyrrolidine 24a
(160 mg, 49 %) as an off-white solid after column chromatography
(CH2Cl2/MeOH, 98:2). 1H NMR (300 MHz, CDCl3): δ = 7.35–7.15 (m,
5 H, Ph), 5.37 (d, J = 4.0 Hz, 1 H, 6′-H), 4.66–4.51 (m, 1 H, 3′-H), 4.52
(dd, J = 10.2, 3.4 Hz, 1 H, 2-H), 3.77 (s, 3 H, CO2CH3), 3.48 (d, J =
8.2 Hz, 1 H, 17′-H), 3.33–3.23 (m, 1 H, 5′′-H), 2.83–2.58 (m, 2 H),
2.58–2.48 (m, 1 H), 2.40–2.10 (m, 4 H), 2.03 (s, 3 H, CH3CO2), 2.00–
1.36 (m, 18 H), 1.23–1.00 (m, 2 H), 1.02 (s, 3 H, 19′-CH3), 0.82 (s, 3
H, 18′-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 173.6 (CO2), 170.4
(CO2), 141.4 (Phipso), 139.4 (C-5′), 128.4, 128.0, 126.0 (Phpara), 122.1
(C-6′), 73.7 (C-3′), 71.2, 68.0, 62.5, 52.4, 49.0, 48.2, 48.0, 45.6, 42.8,
38.1, 36.9, 36.5, 34.1, 33.8, 32.3, 31.9, 31.5, 31.4, 27.7 (C-2′), 21.3
(CH3CO), 20.2 (C-11′), 19.2 (C-19′), 18.1 (C-18′) ppm. HRMS (ESI):
calcd. for C35H49NO5 [M + H]+ 564.36890; found 564.36924.
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